Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Safety, Tolerability, Pharmacokinetics and Pharmacodynamics”

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07024823
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of Creatinine in a Non Interventional Cohort

Who this might be right for
Chronic Kidney Disease
AstraZeneca 124
Early research (Phase 1)Study completedNCT01096160
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK8266 in Hypertensive Men (MK-8266-002)

Who this might be right for
Hypertension
Merck Sharp & Dohme LLC 40
Early research (Phase 1)Study completedNCT01432717
What this trial is testing

Study of ACE-536 in Healthy Postmenopausal Women

Who this might be right for
Anemia
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA 40
Early research (Phase 1)Study completedNCT01025791
What this trial is testing

A Single Dose Study of MK-8266 (MK-8266-001)

Who this might be right for
Hypertension
Merck Sharp & Dohme LLC 25
Testing effectiveness (Phase 2)Study completedNCT01875718
What this trial is testing

A Phase I/II Study to Evaluate UC1010 Treatment in Premenstrual Dysphoric Disorder (PMDD)

Who this might be right for
Premenstrual Dysphoric Disorder
Umecrine Mood AB 146
Early research (Phase 1)Study completedNCT02676596
What this trial is testing

Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of K-312 in Healthy Subjects

Who this might be right for
Hyperlipidemia
Kowa Research Institute, Inc. 120
Early research (Phase 1)Study completedNCT05366634
What this trial is testing

A Single Ascending Dose Study to Evaluate MDK-703 in Healthy Adult Volunteers

Who this might be right for
Healthy Volunteers
Medikine, Inc. 26
Early research (Phase 1)Study completedNCT05858164
What this trial is testing

A First-in-human Study to Learn How Safe the Study Treatment BAY2862789 is, to Find the Best Dose, How it Affects the Body, What Maximum Amount Can be Given, How it Moves Into, Through and Out of the Body, and How it Acts on Different Tumors in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsNon-small Cell Lung Cancer
Bayer 45
Early research (Phase 1)Study completedNCT05891158
What this trial is testing

A Study About Fazirsiran in People With and Without Liver Problems

Who this might be right for
Hepatic Impairment
Takeda 34
Early research (Phase 1)UnknownNCT04524052
What this trial is testing

To Evaluate Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of DWRX2003 Against COVID-19

Who this might be right for
Healthy
Daewoong Pharmaceutical Co. LTD. 32
Very early researchActive Not RecruitingNCT07282652
What this trial is testing

Evaluate the Safety and Tolerability of RAG-18 in Pediatric Patients With Duchenne Muscular Dystrophy

Who this might be right for
Duchenne Muscular Dystrophy (DMD)
Peking Union Medical College Hospital 12
Early research (Phase 1)Study completedNCT02229838
What this trial is testing

Safety/Tolerability, Pharmacokinetics, and Pharmacodynamics of BIBB 1464 MS in Healthy Male Subjects, Combined With Preliminary Evaluation of Relative Bioavailability and Effect of Food

Who this might be right for
Healthy
Boehringer Ingelheim 73
Early research (Phase 1)Study completedNCT00452504
What this trial is testing

Single Ascending Dose Study of SRA-444 in Healthy Subjects

Who this might be right for
Alzheimer Disease
Wyeth is now a wholly owned subsidiary of Pfizer 64
Early research (Phase 1)Study completedNCT04532125
What this trial is testing

SAD and MAD Study With IV and SC Doses of ARGX-117

Who this might be right for
Healthy Volunteers
argenx 110
Early research (Phase 1)Looking for participantsNCT07767487
What this trial is testing

LY4226695 in Healthy Participants

Who this might be right for
Healthy
Eli Lilly and Company 148
Testing effectiveness (Phase 2)Study completedNCT04219826
What this trial is testing

Dose-finding Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CK-3773274 in Adults With Hypertrophic Cardiomyopathy

Who this might be right for
Hypertrophic Cardiomyopathy (HCM)
Cytokinetics 96
Early research (Phase 1)Study completedNCT02639078
What this trial is testing

Single Ascending Dose Study of TD-0714 in Healthy Subjects

Who this might be right for
Healthy
Theravance Biopharma 56
Early research (Phase 1)Looking for participantsNCT07371468
What this trial is testing

GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 44
Testing effectiveness (Phase 2)Study completedNCT00196989
What this trial is testing

Study In People With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 448
Testing effectiveness (Phase 2)Study completedNCT02908685
What this trial is testing

Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of Risdiplam (RO7034067) in Type 2 and 3 Spinal Muscular Atrophy (SMA) Participants

Who this might be right for
Muscular Atrophy, Spinal
Hoffmann-La Roche 231
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation